West Pharmaceutical Services | WST - Umsatzkosten

Aktienkurs
242.36
Täglich Wechseln
5.33 2.25%
Monatlich
-1.23%
Jährlich
4.51%
Q1 Prognose
229.92




Umsatzkosten Veränderung Datum
Align Technology USD 363.97M 7.48M 2025-12
Avanos Medical USD 94.9M 3.1M 2025-12
Baxter International USD 2.4B 512M 2025-12
Becton, Dickinson and Co. USD 2.84B 2.35B 2025-12
Cerus USD 23.42M 3.61M 2024-12
Charles River Laboratories USD 722.27M 28.81M 2025-12
Cooper Companies USD 376.8M 87.4M 2025-12
Dentsply International USD 518M 55M 2025-12
Haemonetics USD 136.58M 4.01M 2025-12
ICU Medical USD 337.72M 1.61M 2025-12
Insulet USD 215.2M 19M 2025-12
Integra LifeSciences USD 193.44M 1.62M 2025-12
IQVIA Holdings USD 3.24B 518M 2025-12
J&J USD 7.97B 689M 2025-12
Medtronic USD 3.61B 83M 2025-12
Merit Medical Systems USD 198.58M 838K 2025-12
Neogen USD 118.01M 3.79M 2025-09
OraSure Technologies USD 15.43M 113K 2025-12
Quidel USD 448.8M 1.21B 2025-12
Repligen USD 94.08M 5.79M 2025-12
Rockwell Medical USD 21.28M 1.67M 2024-06
Solventum Corp USD 971M 8M 2025-12
STAAR Surgical USD 14.06M 2.8M 2025-12
Terumo JPY 143.44B 15.47B 2025-12
Utah Medical Products USD 4.2M 50K 2024-09
West Pharmaceutical Services USD 501.1M 9.2M 2025-12